# CVS HEALTH CORPORATION (CVS) FY2024 YTD Q3 P&L / Income Statement

- Company: CVS HEALTH CORPORATION (CVS)
- Period: 2024-01-01 to 2024-09-30
- Filing: Q3 FY2024 10-Q, filed 2024-11-06, accession number 0000064803-24-000034
- Page: https://plicit.ai/financials/cvs/fy2024-ytd-q3-income-statement
- Chart image: https://plicit.ai/charts/cvs-fy2024-ytd-q3-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2024-01-01 through 2024-09-30. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 275,099,000,000 US dollars
- **Total operating costs**: 268,951,000,000 US dollars
- **Operating income**: 6,148,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 2,126,000,000 US dollars
- **Income before income tax provision**: 4,022,000,000 US dollars
- **Income tax provision**: 1,059,000,000 US dollars
- **Net income**: 2,963,000,000 US dollars
- **Products**: 169,610,000,000 US dollars
- **Services**: 12,108,000,000 US dollars
- **Premiums**: 91,983,000,000 US dollars
- **Net investment income**: 1,398,000,000 US dollars
- **Cost of products sold**: 151,019,000,000 US dollars
- **Health care costs**: 85,578,000,000 US dollars
- **Operating expenses**: 31,185,000,000 US dollars
- **Restructuring charges**: 1,169,000,000 US dollars
- **Loss on assets held for sale**: 0 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to CVS HEALTH CORPORATION: $2.97 B; to noncontrolling interests: −$7.00 M.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/cvs/fy2024-ytd-q3-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/cvs-fy2024-ytd-q3-revenue-by-business-segment-sankey.png

Income statement for 2024-01-01 through 2024-09-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 275,099,000,000 US dollars
- **Total operating costs**: 268,951,000,000 US dollars
- **Operating income**: 6,148,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 2,126,000,000 US dollars
- **Income before income tax provision**: 4,022,000,000 US dollars
- **Income tax provision**: 1,059,000,000 US dollars
- **Net income**: 2,963,000,000 US dollars
- **Health Care Benefits**: 97,707,000,000 US dollars
- **Health Services**: 126,585,000,000 US dollars
- **Pharmacy & Consumer Wellness**: 90,986,000,000 US dollars
- **Cost of products sold**: 151,019,000,000 US dollars
- **Health care costs**: 85,578,000,000 US dollars
- **Operating expenses**: 31,185,000,000 US dollars
- **Restructuring charges**: 1,169,000,000 US dollars
- **Loss on assets held for sale**: 0 US dollars
- **Revenue before reconciliation (calculated)**: 315,278,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Intersegment Eliminations**: negative 40,547,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Corporate/ Other**: 368,000,000 US dollars. Reported reconciliation to consolidated revenue.

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to CVS HEALTH CORPORATION: $2.97 B; to noncontrolling interests: −$7.00 M.